HomeNews ReportsCoronavirus fight: Human trial of vaccine begins in 6 Indian cities, no major side...

Coronavirus fight: Human trial of vaccine begins in 6 Indian cities, no major side effects yet

Dr. Sanjay Rai who serves as the principal investigator of the human trial project at AIIMS Delhi informed that there was no immediate major side effect on a volunteer after he was administered the vaccine.

Amidst the rising cases of Wuhan Coronavirus in India, the human clinical trials for the much-anticipated vaccine has been initiated in six cities. Reportedly, the vaccine candidates of two companies, namely, Bharat Biotech and Zydus Cadila are currently being used for the clinical trials.

As per the report, both the vaccine candidates were approved for Phase I and Phase II trials and they were administered for the first time to volunteers on July 15. Reportedly, another vaccine developed by Oxford University will also be tested in India, on receiving regulatory approval.

Covaxin, developed by Bharat Biotech, is used for human trials in several Indian cities such as Delhi, Hyderabad, Patna, Kancheepuram, and Rohtak. The clinical trials will then be reportedly initiated in other cities including Nagpur, Visakhapatnam, Belgaum, Gorakhpur, and Kanpur. As per reports, while the testing of ZyCov-D developed by Zydus Cadila is limited to Ahmedabad, Covaxin is set to be tested on 500 volunteers between 18 and 55 in 12 different hospitals in 12 different cities. The vaccine candidate is the result of a joint collaboration between the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

No major side effects of Coronavirus vaccine

Dr. Sanjay Rai who serves as the principal investigator of the human trial project at AIIMS Delhi informed that there was no immediate major side effect on a volunteer after he was administered the vaccine.

There are some minor side effects – like redness of the skin where the dose was given, pain and mild fever – which can be seen in any vaccine test. But, it went smoothly without any other health issues. The doctors are continuously monitoring their health, ” PK Singh heading the clinical trials at AIIMS Patna was quoted as saying.

Join OpIndia's official WhatsApp channel

  Support Us  

For likes of 'The Wire' who consider 'nationalism' a bad word, there is never paucity of funds. They have a well-oiled international ecosystem that keeps their business running. We need your support to fight them. Please contribute whatever you can afford

OpIndia Staff
OpIndia Staffhttps://www.opindia.com
Staff reporter at OpIndia

Related Articles

Trending now

Houthis attack Saudi Arabia: Is the Middle East sliding towards another war?

The Houthi attacks on Saudi Arabia could turn Yemen’s proxy war into a wider regional conflagration, as the US-Iran confrontation over the Strait of Hormuz threatens to merge with escalating tensions across the Red Sea and Gulf.

Who is Neem Karoli Baba, the inspiration behind the surprise blockbuster Hanuman Ansh?

Made on a ₹2-crore budget, Dr Vishal Chaturvedi’s Hanuman Ansh has emerged as a massive box-office hit. Based on the life of Neem Karoli Baba, the word-of-mouth phenomenon crossed ₹130 crore nett in India, securing global distribution through Hombale Films.
- Advertisement -